This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Teneobio, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Heather Anne N Ogana: Innovator in Antibody Development
Introduction
Heather Anne N Ogana is a prominent inventor based in Thousand Oaks, California. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic use. Her work focuses on addressing B cell disorders, showcasing her commitment to advancing medical science.
Latest Patents
Heather holds a patent for "Heavy chain antibodies binding to CD22." This patent includes anti-CD22 heavy chain antibodies, such as UniAbs™, and outlines methods for their production. The patent also describes pharmaceutical compositions that incorporate these antibodies and their application in treating B cell disorders characterized by CD22 expression.
Career Highlights
Heather is currently associated with Teneobio, Inc., a company known for its innovative approaches in antibody development. Her role at Teneobio allows her to leverage her expertise in creating effective therapeutic solutions.
Collaborations
Throughout her career, Heather has collaborated with notable colleagues, including Shelley Force Aldred and Wim Van Schooten. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Heather Anne N Ogana is a dedicated inventor whose work in antibody development is making a significant impact in the treatment of B cell disorders. Her innovative spirit and collaboration with esteemed colleagues continue to drive progress in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile